Portal de investigação
Polypill use for the prevention of cardiovascular disease: A position paper
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Araujo, Francisco
- Caldeira, Daniel
- Aguiar, Carlos
- Antunes, Jose Pedro
- Cardim, Nuno
- Cunha, Vitoria
- Moura, Jose P.
- Paixao-Dias, Vitor M.
- Ribeiro, Hugo
- Cruz, Vitor Tedim
Unidades de investigação
Abstract
Cardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, however it is still underused in clinical practice. This paper presents an expert consensus aimed to summarize the data regarding polypill use. The authors consider the benefits of polypill and the significant claims for clinical applicability. Potential advantages and disadvantages, data regarding several populations in primary and secondary prevention, and pharmacoeconomic data are also addressed.(c) 2023 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan similar to a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Dados da publicação
- ISSN/ISSNe:
- 0870-2551, 2174-2030
- Tipo:
- Review
- Páginas:
- 861-872
- PubMed:
- 37172761
- Link para outro recurso:
- www.scopus.com
Revista Portuguesa de Cardiologia Sociedade Portuguesa De Cardiologia
Citações Recebidas na Web of Science: 4
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- Polypill; Cardiovascular; Prevention; Consensus; Primary; Secondary
Projetos associados
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846
Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes
Estudo Observacional Académico (F-CHECK) . Sanofi . 2022
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Citar a publicação
Araujo F,Caldeira D,Aguiar C,Antunes JP,Cardim N,Cunha V,Fonseca L,Moura JP,Paixao VM,Ribeiro H,Cruz VT,Gavina C. Polypill use for the prevention of cardiovascular disease: A position paper. Rev Port Cardiol. 2023. 42(10):p. 861-872. IF:1,800. (4).
